Fludarabine, cyclophosphamide and mitoxantrone in relapsed or refractory chronic lymphocytic leukemia and low grade non-Hodgkin's lymphoma

Leukemia and Lymphoma

Volumn 45, Issue 5, 2004, Pages 945-950

  Hendry, L ^a   Bowen, A ^b   Matutes, E ^a   Swansbury, J ^a   Catovsky, Daniel ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b NORTHAMPTON GENERAL HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

CLL; Cyclophosphamide; Fludarabine; Mitoxantrone; Non Hodgkins lymphoma

Indexed keywords

ALEMTUZUMAB; ANTIEMETIC AGENT; CHLORAMBUCIL; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUDARABINE; GRANISETRON; GRANULOCYTE COLONY STIMULATING FACTOR; METHYLPREDNISOLONE; MITOXANTRONE; PREDNISOLONE; VINCRISTINE SULFATE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD TOXICITY; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; HERPES ZOSTER; HUMAN; INFECTIOUS COMPLICATION; KIDNEY DYSFUNCTION; LARGE CELL LYMPHOMA; MALE; MALIGNANT TRANSFORMATION; NEUTROPENIA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; THROMBOCYTOPENIA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LEUKEMIA, MYELOID; LYMPHOMA, LARGE-CELL; LYMPHOMA, LOW-GRADE; MALE; MIDDLE AGED; MITOXANTRONE; NEOPLASMS, SECOND PRIMARY; NEUTROPENIA; OPPORTUNISTIC INFECTIONS; REMISSION INDUCTION; SALVAGE THERAPY; SURVIVAL ANALYSIS; VIDARABINE;

EID: 1842450530     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190310001639489     Document Type: Article

References (31)

1. Hiddemann, W., Rottmann, R., Wormann, B., Theil, A., Essink, M., Ottensmeier, C., et al. (1991) "TReatment of advanced chronic lymphocytic leukaemia by fludarabine: Results of a clinical study", Ann. Haematol., 63, 1-4.
2. Fenchel, K., Bergmann, L., Wijermans, P., Engert, A., Pralle, H., Mitrou, P.S., et al. (1995) "CLinical experience with fludarabine and its immunosuppressive effects in pre-treated chronic lymphocytic leukemias and low-grade lymphomas", Leukemia Lymphoma, 18, 485-492.
3. Johnson, S., Smith, A.G., Loffler, H., Osby, E., Juliusson, G., Emmerich, B., et al. (1996) "MUlti-centre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin and prednisolone (CAP) for treatment of advanced stage chronic lymphocytic leukaemia. The French Co-operative Group on CLL", Lancet, 347, 1432-1438.
4. Montserrat, E., Lopez-Lorenzo, J.L., Manso, F., Martin, A., Prieto, E., Arias-Sampedro, J., et al. (1996) "FLudarabine in resistant or relapsing B-cell chronic lymphocytic leukemia: The Spanish Group experience", Leukemia and Lymphoma, 21, 467-472.
5. Rai, K.R., Peterson, B., Applebaum, F.R., Kolitz, J., Elias, L., Shepherd, L., et al. (2000) "FLudarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia", N. Engl. J. Med., 343, 1750-1757.
6. Keating, M., O'Brien, S., Lerner, S., Koller, C., Beran, M., Robertson, L.E., et al. (1998) "LOng-term follow up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy", Blood, 92, 1165-1171.
7. Koel, U., Li, L., Nowak, B., Ruiz van Haperen, V., Kornhuber, B., Schwabe, D., et al. (1997) "FLudarabine and cyclophosphamide: Synergistic cytotoxicity associated with inhibition of interstrand cross-link removal", Proc. Am. Assoc. Cancer Res., 38, 2
8. Bellosillo, B., Villamor, N., Colomer, D., Pons, G., Montserrat, E., and Gil, J. (1999) "IN vitro evaluation of fludarabine in combination with cyclophosphamide and/or mitoxantrone in B-cell chronic lymphocytic leukemia", Blood, 94, 2836-2843.
9. Frewin, R., Turner, D., Tighe, M., Davies, S., Rule, S. and Johnson, S. (1999) "COmbination therapy with fludarabine and cyclophosphamide as salvage treatment in lymphoproliferative disorders", British Journal of Haematology, 104, 612-613.
10. Flinn, I.W., Byrd, J.C., Morrison, C., Jamison, J., Diehl, L.F., Murphy, T., et al. (2000) "FLudarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies", Blood, 96, 71-75.
11. Hochster, H., Oken, M., Bennett, J., Winter, J.N., Gordon, L.I., Raphael, B.G., et al. (2000) "PHase 1 study of fludarabine plus cyclophosphamide in patients with previously untreated low- grade lymphoma: Results and long-Aerm follow up: a report from the Eastern Co-operative Oncology Group", Journal of Clinical Oncology, 18, 987-994.
12. Marotta, G., Bigazzi, C., Lenoci, M., Tozzi, M., Bocchia, M. and Lauria, F. (2000) "LOw-dose fludarabine and cyclophosphamide in elderly patients with B-cell chronic lymphocytic leukaemia refractory to conventional therapy", Haematologica, 85, 1268-1270.
13. Hallek, M., Schmitt, B., Wilhelm, M., Busch, R., Krober, A., Fostitsch, H.P., et al. (2001) "FLudarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic; leukaemia (CLL): results of a phase II study of the German CLL study group", British Journal of Haematology, 114, 342-348.
14. O'Brien, S.M., Kantarjian, H.M., Cortes, J., Beran, M., Koller, C.A., Giles, F.J., et al. (2001) "REsults of the Fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia", Journal of Clinical Oncology, 19, 1414-1420.
15. McLaughlin, P., Hagemeister, F.B., Romaguera, J.E., Sarris, A.H., Pate, O., Younes, A., et al. (1996) "FLudarabine, mitoxantrone and dexamethasone: An effective new regimen for indolent lymphoma", Journal of Clinical Oncology, 14, 1262-1268.
16. Robertson, L.E., O'Brien, S., Kantarjian, H., Koller, C., Beran, M., Andreeff, M., et al. (1995) "FLudarabine plus doxorubicin in previously treated chronic lymphocytic leukemia", Leukemia, 9, 943-945.
17. Zinzani, P.L., Magagnoli, M., Bendandi, M., Gherlinzoni, F., Orcioni, G.F., Cellini, C., et al. (2000) "EFficacy of fludarabine and mitoxantrone (FN) combination regimen in untreated indolent non-Hodgkin's lymphomas", Annuals of Oncology, 11, 363-365.
18. Rummel, M.J., Kafer, G., Pfreundschuh, M., Jager, E., Reinhardt, U., Mitrou, P.S., et al. (1999) "FLudarabine and epirubicin in the treatment of chronic lymphocytic leukaemia: A German multicenter phase II study", Annals of Oncology, 10, 183-188.
19. Gregory, S.A., Vose, J., Modiano, M., Kraemer, K., Rifkin, R., Rubin, A., et al. (2001) "MItoxantrone and fludarabine in the treatment of patients with non-Hodgkin's lymphoma failing primary therapy with a doxorubicin or mitoxantrone-containing regimen", Leukemia and Lymphoma, 40, 315-324.
20. Santini, G., Nati, S., Spriano, M., Gallamini, A., Pierluigi, D., Congiu, A.M., et al. (2001) "FLudarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphoma", Haematologica, 86, 282-286.
21. Bocchia, M., Bigazzi, C., Marconcini, S., Forconi, F., Marotta, G., Algeri, R., et al. (1999) "FAvourable impact of low dose fludarabine plus epirubicin and cyclophosphamide regimen (FLEC) as treatment for low-grade non-Hodgkin's lymphomas", Haematologica, 84, 716-720.
22. Bosch, F., Ferrer, A., Lopez-Guillermo, A., Gine, E., Bellosillo, B., Villamor, N., et al. (2002) "FLudarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemia", British Journal of Haematology, 119, 976-984.
23. Schmitt, B.F., Franke, A., Burkhard, O., Schlag, R., Hopfinger, G., Stauch, M., et al. (2002) "FLudarabine, Mitoxantrone and Cyclophosphamide combination therapy in relapsed chronic lymphocytic leukemia with or without G-CSF: Results of the first interim analysis of a phase III study of the German CLL Group", Blood, 100, 364b (abstract 5015).
24. Mauro, F.R., Foa, R., Meloni, G., Gentile, M., Giammartini, E., Giannarelli, D., et al. (2002) "FLudarabine, ara-C novantrone and dexamethasone (FAND) in previously treated chronic lymphocytic leukaemia patients", Haematologica, 87, 926-933.
25. Zaja, F., Rogato, A., Russo, D., Marin, L., Silvestri, F. and Baccarani, M. (1997) "COmbined therapy with fludarabine and cyclophosphamide in relapsed/resistant patients with B-cell chronic lymphocytic leukaemia and non-Hodgkin's lymphomas", European Journal of Haematology, 59, 327-328.
26. Lazzarino, M., Orlandi, E., Baldanti, F., Furione, M., Pagnucco, G., Astori, C., et al. (1999) "THe immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disorders", British Journal of Haematology, 107, 877-882.
27. Lossos, I.S., Paltiel, O. and Polliack, A. (1999) "SAlvage chemotherapy using a combination of fludarabine and cyclophosphamide for refractory or relapsing indolent and aggressive non-Hodgkin's lymphomas", Leukemia Lymphoma, 33, 155-160.
28. Saso, R., Kulkarni, S., Mitchell, P., Treleaven, J., Swansbury, G.J., Mehta, J., et al. (2000) "SEcondary myelodysplastic syndrome/ acute myeloid leukaemia following mitoxantrone based therapy for breast carcinoma", British Journal of Cancer, 83, 91-94.
29. Pedersen-Bjergaard, J., Andersen, M.K. and Johansson, B. (1998) "BAlanced chromosome aberrations in leukemias following chemotherapy with DNA-topoisomerase II inhibitors", Journal of Clinical Oncology, 16, 1897-1898.
30. Morrison, V.A., Rai, K.R., Peterson, B.L., Kolitz, J.E., Elias, L., Appelbaum, F.R., et al. (2002) "THerapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: Results of an intergroup study, cancer and leukemia group B 9011", The Journal of Clinical Oncology, 20, 3878-3884.
31. Hiddemann, W., Dreyling, M. and Unterhalt, M. (2003) "RItuximab plus chemotherapy in follicular and mantle cell lymphomas", Seminars In Oncology, 30(suppl. 2), 16-20.